BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36719455)

  • 21. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1].
    Mestre-Alagarda C; Gómez-Mateo MC; Berenguer-Romero MD; Syonghyun NC; Nieto G; Navarro-Fos S
    Rev Esp Patol; 2022; 55(1):57-62. PubMed ID: 34980443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphenotypic Sinonasal Sarcoma: A Review and Update.
    Carter CS; East EG; McHugh JB
    Arch Pathol Lab Med; 2018 Oct; 142(10):1196-1201. PubMed ID: 30281368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site?
    Mechtersheimer G; Andrulis M; Delank KW; Volckmar AL; Zhang L; von Winterfeld M; Stenzinger A; R Antonescu C
    Genes Chromosomes Cancer; 2021 Aug; 60(8):565-570. PubMed ID: 33715240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orbital Involvement by Biphenotypic Sinonasal Sarcoma With a Literature Review.
    Hanbazazh M; Jakobiec FA; Curtin HD; Lefebvre DR
    Ophthalmic Plast Reconstr Surg; 2021 Jul-Aug 01; 37(4):305-311. PubMed ID: 32991500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma.
    Wang X; Bledsoe KL; Graham RP; Asmann YW; Viswanatha DS; Lewis JE; Lewis JT; Chou MM; Yaszemski MJ; Jen J; Westendorf JJ; Oliveira AM
    Nat Genet; 2014 Jul; 46(7):666-8. PubMed ID: 24859338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological progression of biphenotypic sinonasal sarcoma to high-grade sarcoma at 7 years from onset.
    Bellan E; Patriarca C; Dei Tos AP; Sbaraglia M
    Histopathology; 2023 Nov; 83(5):825-826. PubMed ID: 37644669
    [No Abstract]   [Full Text] [Related]  

  • 27. Biphenotypic Sinonasal Sarcoma: Case Reports of Diagnostic Findings and Clinical Management of 3 Cases.
    Augustin Y; Zaidi S; Jones RL; Benson C; Simcock R; Fisher C; Thway K; Hallin M; Miah AB
    Anticancer Res; 2023 Apr; 43(4):1581-1589. PubMed ID: 36974788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biphenotypic sinonasal sarcoma: Report of 3 cases with a review of literature.
    Sethi S; Cody B; Farhat NA; Pool MD; Katabi N
    Hum Pathol (N Y); 2021 Jun; 24():. PubMed ID: 34660202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sinonasal rhabdomyosarcoma in children and young adults.
    Ahmed AA; Tsokos M
    Int J Surg Pathol; 2007 Apr; 15(2):160-5. PubMed ID: 17478770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small Biopsy Samples: Are They Representative for Biphenotypic Sinonasal Sarcoma?
    Kuczkiewicz-Siemion O; Prochorec-Sobieszek M; Rysz M; Wojnowska A; Durzyńska M
    Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion of the Paired Box 3 (
    Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Tafjord S; Micci F; Heim S
    Cancer Genomics Proteomics; 2021; 18(6):723-734. PubMed ID: 34697065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biphenotypic sinonasal sarcoma - a case report.
    Bartoš V; Rác P; Skálová A
    Klin Onkol; 2022; 35(5):402-406. PubMed ID: 36443095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells.
    Calhabeu F; Hayashi S; Morgan JE; Relaix F; Zammit PS
    Oncogene; 2013 Jan; 32(5):651-62. PubMed ID: 22710712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sinonasal Tract Alveolar Rhabdomyosarcoma in Adults: A Clinicopathologic and Immunophenotypic Study of Fifty-Two Cases with Emphasis on Epithelial Immunoreactivity.
    Thompson LDR; Jo VY; Agaimy A; Llombart-Bosch A; Morales GN; Machado I; Flucke U; Wakely PE; Miettinen M; Bishop JA
    Head Neck Pathol; 2018 Jun; 12(2):181-192. PubMed ID: 28875443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
    Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
    J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonal and alveolar rhabdomyosarcoma of parameningeal sites in adults: a report of 13 cases.
    Montone KT; Barr FG; Zhang PJ; Feldman MD; LiVolsi VA
    Int J Surg Pathol; 2009 Feb; 17(1):22-30. PubMed ID: 18945709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphenotypic Sinonasal Sarcoma: A Case Report and Review of Literature.
    Kominsky E; Boyke AE; Madani D; Kamat A; Schiff BA; Agarwal V
    Ear Nose Throat J; 2023 Jun; 102(6):385-390. PubMed ID: 33813901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapidly progressive congenital rhabdomyosarcoma presenting with multiple cutaneous lesions: an uncommon diagnosis and a therapeutic challenge.
    Rekhi B; Qureshi SS; Narula G; Gujral S; Kurkure P
    Pathol Res Pract; 2014 May; 210(5):328-33. PubMed ID: 24635971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biphenotypic Sinonasal Sarcoma with PAX7 Expression.
    Georgantzoglou N; Green D; Stephen SA; Kerr DA; Linos K
    Int J Surg Pathol; 2022 Sep; 30(6):642-645. PubMed ID: 35147045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.